Skip to content

Clinical trials

Phase 2 Ischemic Stroke trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 2 Country / region: Austria Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20051
20061
20091
20131
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc2
Bayer1
Bristol-Myers Squibb1
PAION Deutschland GmbH1
Sygnis Bioscience GmbH & Co KG1
Technische Universität Dresden1
ThromboGenics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke8
Stroke4
Ischemic Attack, Transient1
Sleep Apnea Syndromes1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.